Serial Number | 97348831 |
Word Mark | ACZEBLY |
Filing Date | Wednesday, April 6, 2022 |
Status | 733 - FOURTH EXTENSION - GRANTED |
Status Date | Wednesday, December 11, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 1, 2022 |
Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 11, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Event Date | Event Description |
Saturday, April 9, 2022 | NEW APPLICATION ENTERED |
Monday, April 11, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 20, 2022 | ASSIGNED TO EXAMINER |
Monday, September 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, October 12, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 1, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, November 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, December 27, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, June 27, 2023 | SOU EXTENSION 1 FILED |
Monday, July 31, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Monday, July 31, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Tuesday, August 1, 2023 | TEAS PETITION TO REVIVE RECEIVED |
Tuesday, August 1, 2023 | PETITION TO REVIVE-GRANTED |
Tuesday, August 1, 2023 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
Wednesday, August 2, 2023 | NOTICE OF REVIVAL - E-MAILED |
Tuesday, August 29, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, August 30, 2023 | SOU EXTENSION 1 GRANTED |
Thursday, August 31, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, December 20, 2023 | SOU TEAS EXTENSION RECEIVED |
Wednesday, December 20, 2023 | SOU EXTENSION 2 FILED |
Wednesday, December 20, 2023 | SOU EXTENSION 2 GRANTED |
Friday, December 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, June 18, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, June 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, June 18, 2024 | SOU EXTENSION 3 GRANTED |
Tuesday, June 18, 2024 | SOU EXTENSION 3 FILED |
Wednesday, December 11, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, December 11, 2024 | SOU EXTENSION 4 FILED |
Wednesday, December 11, 2024 | SOU EXTENSION 4 GRANTED |
Wednesday, December 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |